GASTALDELLI, AMALIA

GASTALDELLI, AMALIA  

Istituto di Fisiologia Clinica - IFC  

Mostra records
Risultati 1 - 20 di 412 (tempo di esecuzione: 0.055 secondi).
Titolo Data di pubblicazione Autore(i) File
Succinate Modulation as a Biochemical Correlate of Metabolic and Neurobehavioral Changes Associated With Intermittent Fasting in Obesity 1-gen-2026 Tognozzi, Andrea; Carli, Fabrizia; Abdelkarim, Sherif; Cornuti, Sara; Damiani, Francesca; Giuliano, Maria Grazia; Miniati, Alice; Nasisi, Martina; De Benedictis, Lia; Ashtiani, Kousha Changizi; Scabia, Gaia; Maffei, Margherita; Baldi, Pierre; Gastaldelli, Amalia; Tognini, Paola
Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes 1-gen-2025 Triplitt, C.; Cersosimo, E.; Alatrach, M.; Adams, J.; Hansis-Diarte, A.; Baskoy, G.; Gastaldelli, A.; Chavez-Velazquez, A.; Defronzo, R. A.
Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease 1-gen-2025 Caviglia, G. P.; Casalone, E.; Rosso, C.; Aneli, S.; Allione, A.; Carli, F.; Grange, C.; Armandi, A.; Catalano, C.; Birolo, G.; Foglia, B.; Ribaldone, D. G.; Gastaldelli, A.; Matullo, G.; Bugianesi, E.
ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine 1-gen-2025 Russo, S.; Proto, L.; Neto, M. G.; Angelini, G.; Pezzica, S.; Carli, F.; Previti, E.; Caristo, M. E.; Bove, V.; Chakaroun, R.; Roggiani, S.; Tremaroli, V.; Le Roux, C. W.; Bornstein, S. R.; Gastaldelli, A.; Boskoski, I.; Mingrone, G.
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis 1-gen-2025 Younossi, Z. M.; Zelber-Sagi, S.; Lazarus, J. V.; Wong, V. W. -S.; Yilmaz, Y.; Duseja, A.; Eguchi, Y.; Castera, L.; Pessoa, M. G.; Oliveira, C. P.; El-Kassas, M.; Tsochatzis, E.; Fan, J. -G.; Spearman, C. W.; Tacke, F.; Castellanos Fernandez, M. I.; Alkhouri, N.; Schattenberg, J. M.; Romero-Gomez, M.; Noureddin, M.; Allen, A. M.; Ong, J. P.; Roberts, S. K.; Shubrook, J. H.; Burra, P.; Kohli, R.; Kautz, A.; Holleboom, A. G.; Lam, B.; Isaacs, S.; Macedo, P.; Gastaldelli, A.; Henry, L.; Ivancovsky-Wajcman, D.; Nader, F.; De Avila, L.; Price, J. K.; Mark, H. E.; Villota-Rivas, M.; Barbera, A.; Kalligeros, M.; Gerber, L. H.; Alqahtani, S. A.
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: Rationale and design of a prospective multicentre study 1-gen-2025 De Jong, V. D.; Alings, M.; Bruha, R.; Cortez-Pinto, H.; Dedoussis, G. V.; Doukas, M.; Francque, S.; Fournier-Poizat, C.; Gastaldelli, A.; Hankemeier, T.; Holleboom, A. G.; Miele, L.; Moreno, C.; Muris, J. W. M.; Ratziu, V.; Romero-Gomez, M.; Schattenberg, J. M.; Serfaty, L.; Stefan, D. C.; Tushuizen, M. E.; Verheij, J.; Willemse, J.; Franco, O. H.; Grobbee, D. E.; Castro Cabezas, M.
Growth Hormone Promotes Hepatic Triglyceride Export in Humans 1-gen-2025 Baumgartner, C.; Metz, M.; Beghini, M.; Pfleger, L.; Tosin, A.; Koldyka, O.; Beiglbock, H.; Fellinger, P.; Vila, G.; Luger, A.; Kautzky-Willer, A.; Freudenthaler, A.; Baumgartner-Parzer, S.; Stangl, H.; Krssak, M.; Carli, F.; Infelise, P.; Gastaldelli, A.; Scherer, T.; Krebs, M.; Wolf, P.
Lipidomic profiling unveils sex differences in diabetes risk: Implications for precision medicine 1-gen-2025 Pina, A. F.; Meneses, M. J.; Carli, F.; Ribeiro, R. T.; Gardete-Correia, L.; Boavida, J. M.; Raposo, J. F.; Gastaldelli, A.; Macedo, M. P.
NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) - Why the Need for a Change of Nomenclature? 1-gen-2025 Gastaldelli, A.; Newsome, P. N.
Reduced prandial insulin secretion contributes to prandial hyperglycaemia in non-diabetic individuals with spinal cord injury 1-gen-2025 Trbovich, M.; Hoekstra, S.; Gastaldelli, A.; Salehi, M.
Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents 1-gen-2025 Gastaldelli, A.
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features 1-gen-2024 Lori, G.; Pastore, M.; Navari, N.; Piombanti, B.; Booijink, R.; Rovida, E.; Tusa, I.; Lewinska, M.; Andersen, J. B.; Lottini, T.; Arcangeli, A.; Taddei, M. L.; Pranzini, E.; Mancini, C.; Anceschi, C.; Madiai, S.; Sacco, E.; Rota, S.; Trapani, A.; Agrimi, G.; Ramazzotti, M.; Ostano, P.; Peraldo Neia, C.; Parri, M.; Carli, F.; Sabatini, S.; Gastaldelli, A.; Marra, F.; Raggi, C.
Baseline phenotypes with preserved β-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies 1-gen-2024 Sabatini, S.; Nolan, J. J.; O(')Donoghue, G.; Kennedy, A.; Petrie, J.; Walker, M.; O(')Gorman, D. J.; Gastaldelli, A.
Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery 1-gen-2024 Honka, H.; Gastaldelli, A.; Pezzica, S.; Peterson, R.; Defronzo, R.; Salehi, M.
Dodecanedioic acid prevents and reverses metabolic‐associated liver disease and obesity and ameliorates liver fibrosis in a rodent model of diet‐induced obesity 1-gen-2024 Angelini, Giulia; Russo, Sara; Carli, Fabrizia; Infelise, Patrizia; Panunzi, Simona; Bertuzzi, Alessandro; Caristo, Maria Emiliana; Lembo, Erminia; Calce, Roberta; Bornstein, Stefan R.; Gastaldelli, Amalia; Mingrone, Geltrude
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 1-gen-2024 Tacke, F.; Horn, P.; Wong, V. W. -S.; Ratziu, V.; Bugianesi, E.; Francque, S.; Zelber-Sagi, S.; Valenti, L.; Roden, M.; Schick, F.; Yki-Jarvinen, H.; Gastaldelli, A.; Vettor, R.; Fruhbeck, G.; Dicker, D.
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) 1-gen-2024 Tacke, F.; Horn, P.; Wai-Sun Wong, V.; Ratziu, V.; Bugianesi, E.; Francque, S.; Zelber-Sagi, S.; Valenti, L.; Roden, M.; Schick, F.; Yki-Jarvinen, H.; Gastaldelli, A.; Vettor, R.; Fruhbeck, G.; Dicker, D.
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary 1-gen-2024 Dicker, D.; Fruhbeck, G.; Vettor, R.; Gastaldelli, A.; Yki-Jarvinen, H.; Schick, F.; Roden, M.; Valenti, L.; Zelber-Sagi, S.; Francque, S.; Bugianesi, E.; Ratziu, V.; Wong, V. W. -S.; Horn, P.; Tack, F.
Effects of Mixtures of Emerging Pollutants and Drugs on Modulation of Biomarkers Related to Toxicity, Oxidative Stress, and Cancer 1-gen-2024 Manuguerra, Simona; Carli, Fabrizia; Scoditti, Egeria; Santulli, Andrea; Gastaldelli, Amalia; Messina, Concetta Maria
ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model 1-gen-2024 Angelini, Giulia; Galvao Neto, Manoel; Boskoski, Ivo; Caristo, Maria Emiliana; Russo, Sara; Proto, Luca; Previti, Elena; Olsson, Lisa; Aggarwal, Hobby; Pezzica, Samantha; Ferrari, Elisa; Bove, Vincenzo; Genco, Alfredo; Bornstein, Stefan; Tremaroli, Valentina; Gastaldelli, Amalia; Mingrone, Geltrude